Reprogramming of somatic cells to pluripotent stem cells is an intriguing biological phenomenon that can be achieved by multiple approaches. Takahashi and Yamanaka have demonstrated that ectopic expression of transcription factors (TFs), Oct3/4, Sox2, Klf4, and Myc, in somatic cells results in generation of induced pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006) . Then, the replacement of each TFs by small molecule chemicals has been assessed in a stepby-step manner, and finally reprogramming by chemicals only, designated as chemical reprogramming, has been achieved (Hou et al., 2013) . Chemical reprogramming has several advantages comparing to TF-mediated reprogramming, but its poor efficiency and long time course are problematic. In this issue of Cell, Zhao et al. (Zhao et al., 2015) demonstrate a significant improvement in efficiency and kinetics of chemical reprogramming and also reveal the unique character of reprogramming pathway from somatic cells to chemically induced pluripotent stem cells (CiPSCs).
Reprogramming of somatic cells to iPSCs is a slow process that consists of multiple steps. The first step is erasing the genetic and epigenetic programs from the original cell identity. The next step is the gradual shift toward pluripotent state, followed by the final step to establish autonomous pluripotent state and complete reprogramming (Theunissen and Jaenisch, 2014) . However, these steps occur continuously, and there is no clear evidence of stable intermediate state mimicking the characteristics of particular cell types that exist in the physiological or developmental context. In the case of reprogramming of human fibroblasts, it has been reported that the intermediate step mimics the character of mesoendoderm cells although it is not stably captured in culture (Figure 1 ) (Takahashi et al., 2014) .
The chemical reprogramming with the previous protocol takes a longer period with transient upregulation of endodermassociated genes (Hou et al., 2013) .
Here, the authors demonstrate that the expression of the endoderm markers is not only a hallmark but coupled with the existence of a stable intermediate state (Figure 1 ) (Zhao et al., 2015) . The successful capture of the cells at this intermediate state in culture allows them to reveal that these cells have a strong resemblance to embryo-derived extraembryonic endoderm (eXEN) cells. eXEN cells are derived from primitive endoderm cells in late blastocyst stage embryos and continue to propagate in culture while retaining their ability to contribute to extraembryonic cell lineage after injection into blastocysts (Kunath et al., 2005) . (Shu et al., 2013) . Although the process of the reprogramming by these lineage-specifying TFs has not been analyzed, the cells subjected to this method may also pass through the XEN-like state.
Alternatively, since mesoderm-related genes such as C/EBPa are also able to replace Oct3/4, the primary function of these TFs may be the perturbation of the TF network to define the original cell identity rather than instructing a particular differentiation event. Interestingly, C/EBPa is also known as the factor to prime the competency for reprogramming in B cells. Di Stefano et al. have demonstrated that the transient expression of C/EBPa before induction of the four Yamanaka TFs dramatically increases the efficiency of reprogramming, to almost a deterministic level (Di Stefano et al., 2014) . Physiologically, C/EBPa is involved in the formation of macrophage/granulocyte progenitors (GMPs); and Emili et al. have reported that GMPs are also hyper-competent to be reprogrammed by four Yamanaka TFs (Eminli et al., 2009 (Figure 1) (Hou et al., 2013) . These reprogramming steps should be followed by the culture in 2i-medium containing CHIR99021 and PD0325901 (Ying et al., 2008) . The whole process takes 48-60 days and the efficiency is quite low: only 1 CiPSC colony from 40,000 initial cells. Here, AM580 and EPZ004777 are added in step 1, and SGC0946 and 5-aza-dC in step 2, with optimization of the dose of CHIR99021, resulting in a dramatic improvement in both the efficiency and kinetics (Figure 1) . Using the new protocol, 1,000-9,000 CiPSC colonies have been obtained from 50,000 initial cells within 40 days. The new protocol is applicable not only for MEFs but also for neonatal dermal fibroblasts and adult lung fibroblasts. Identification of the key intermediate state will work as a stepping stone to establish a modified protocol for the application of chemical reprogramming in human cells.
York et al. identify a role for decreased cholesterol biosynthesis in virally infected cells as a critical event in the induction of the anti-viral response. The mechanism involves enhanced signaling by STING in the ER membrane in response to the second messenger cGAMP, promoting increased transcription of type I interferons. The authors suggest that a ''lipid code'' is being sensed by STING to allow it to signal.
Metabolic reprogramming (meaning a reconfiguring of metabolic pathways) occurs in immune cells during challenge with pathogens, their products, or the cytokines that they elicit (Ganeshan and Chawla, 2014; Kelly and O'Neill, 2015) . We still have an incomplete understanding of why these changes occur. Lipid metabolism has been a particular focus, with, for example, the Gram-negative bacterial product LPS signaling via TLR4 downregulating cholesterol biosynthesis, as anti-viral type I interferons do (IFNs) (Blanc et al., 2013) . Paradoxically, type I IFNs have also been shown to promote cholesterol uptake in the face of this decreased biosynthesis (Boshuizen et al., 2015) . In this issue of Cell, York et al. (2015) address this apparently neutral change in cholesterol levels head on and demonstrate that type I IFN signaling indeed shifts the balance away from biosynthesis to uptake of cholesterol. Strikingly, however, they demonstrate that the decrease in cholesterol biosynthesis promotes anti-viral gene expression by the key anti-viral signaling protein STING. STING appears to require a cholesterol-deficient endoplasmic reticulum (ER) membrane from which to signal for type I IFN production. These findings therefore identify a clear molecular consequence for decreased cholesterol synthesis in anti-viral immunity.
The authors begin their study by measuring total and synthesized cholesterol levels in macrophages treated with IFN b, Poly:IC, or LPS or infected with murine gammaherpesvirus-68 (MHV-68). All of these decreased synthesis of cholesterol while increasing the total cholesterol levels in cells. The uptake of cholesterol (contained in LDL particles) was enhanced. Infection with MHV-68 decreased the expression of genes encoding enzymes in the cholesterol biosynthetic pathway and increased expression of genes encoding lipid importers. The effect of MHV-68 was IFN dependent, indicating that it is the induced type I IFN that reprograms cholesterol metabolism
